These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3001484)

  • 21. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.
    Bancroft GJ; Shellam GR; Chalmer JE
    J Immunol; 1981 Mar; 126(3):988-94. PubMed ID: 6257788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.
    Almishaal AA; Mathur PD; Hillas E; Chen L; Zhang A; Yang J; Wang Y; Yokoyama WM; Firpo MA; Park AH
    PLoS Pathog; 2017 Aug; 13(8):e1006599. PubMed ID: 28859161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine peritoneal macrophages support murine cytomegalovirus replication.
    Shanley JD; Pesanti EL
    Infect Immun; 1983 Sep; 41(3):1352-9. PubMed ID: 6309668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of biological response modifiers on murine cytomegalovirus infection.
    Ebihara K; Minamishima Y
    J Virol; 1984 Jul; 51(1):117-22. PubMed ID: 6202880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyadenylic: polyuridylic acid-induced determinants of host resistance to cytomegalovirus and their potentiation by hyperthermia.
    Lee BK; Mohrman M; Odean MJ; Johnson AG; Morin A; Deschamps de Paillette E
    J Immunother (1991); 1992 Aug; 12(2):105-14. PubMed ID: 1324000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection.
    Kunder SC; Wu L; Morahan PS
    Antiviral Res; 1993 Jun; 21(2):103-18. PubMed ID: 8393316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match.
    Webb JR; Lee SH; Vidal SM
    Genes Immun; 2002 Aug; 3(5):250-62. PubMed ID: 12140743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication.
    Natuk RJ; Welsh RM
    J Immunol; 1987 Feb; 138(3):877-83. PubMed ID: 3027167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.
    Bukowski JF; Warner JF; Dennert G; Welsh RM
    J Exp Med; 1985 Jan; 161(1):40-52. PubMed ID: 2981954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
    Bukowski JF; Woda BA; Habu S; Okumura K; Welsh RM
    J Immunol; 1983 Sep; 131(3):1531-8. PubMed ID: 6309965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural cytotoxicity of murine cytomegalovirus-infected cells mediated by mouse lymphoid cells: role of interferon in the endogenous natural cytotoxicity reaction.
    Lee GD; Keller R
    Infect Immun; 1982 Jan; 35(1):5-12. PubMed ID: 6172385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of natural killer cells in the pathogenesis of murine cytomegalovirus interstitial pneumonitis and the immune response to infection.
    Quinnan GV; Manischewitz JF; Kirmani N
    J Gen Virol; 1982 Jan; 58 Pt 1():173-80. PubMed ID: 6292342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.
    Welsh RM; Brubaker JO; Vargas-Cortes M; O'Donnell CL
    J Exp Med; 1991 May; 173(5):1053-63. PubMed ID: 1850779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity.
    Selgrade MK; Daniels MJ; Hu PC; Miller FJ; Graham JA
    Infect Immun; 1982 Dec; 38(3):1046-55. PubMed ID: 6295940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of MDP-Lys(L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection.
    Eizuru Y; Nakagawa N; Hamasuna R; Minamishima Y
    Nat Immun; 1992; 11(4):225-36. PubMed ID: 1384831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus.
    Orr MT; Beilke JN; Proekt I; Lanier LL
    Proc Natl Acad Sci U S A; 2010 Sep; 107(36):15844-9. PubMed ID: 20733071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking Effector and Memory NK Cells During MCMV Infection.
    Beaulieu AM; Sun JC
    Methods Mol Biol; 2016; 1441():1-12. PubMed ID: 27177652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory and immunological responses to murine cytomegalovirus in resistant CBA mice.
    Price P; Winter JG; Eddy KS; Shellam GR
    Arch Virol; 1989; 104(1-2):35-51. PubMed ID: 2538112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective activity of the lipid A analogue GLA-60 against murine cytomegalovirus infection in immunodeficient mice.
    Ikeda S; Neyts J; Matsuura M; Kiso M; Hasegawa A; Nishimura C; De Clercq E
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1399-403. PubMed ID: 8393081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus.
    Noda S; Tanaka K; Sawamura S; Sasaki M; Matsumoto T; Mikami K; Aiba Y; Hasegawa H; Kawabe N; Koga Y
    J Immunol; 2001 Mar; 166(5):3533-41. PubMed ID: 11207313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.